A carregar...
Liquid biopsy for lung cancer immunotherapy
The recent successful use of the immune checkpoint inhibitors (CPIs) anti-programmed death receptor-1 (PD-1)/PD-1 ligand 1 in clinical trials indicates their crucial role in obtaining an effective cancer immune therapy. These CPIs have been identified to have an effective therapeutic response, parti...
Na minha lista:
| Publicado no: | Oncol Lett |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
D.A. Spandidos
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6507432/ https://ncbi.nlm.nih.gov/pubmed/31186680 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2019.10166 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|